Transforming Testing with Innovation
Intelligent Bio Solutions' mission is to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life. The company's Intelligent Fingerprinting Drug Testing Solution is the first drug testing solution to use fingerprint sweat to screen for common drugs of abuse, including opiates, cocaine, methamphetamine, and cannabis. The company is addressing global drug issues in addition to the challenges associated with traditional drug testing methods such as adulteration, invasion of employee's basic privacy, and sample collection barriers such as nil by mouth.
With over 1,800 installed readers, sales across 31 countries, and more than 480 active customer accounts, the company's fingerprint sweat-based drug testing technology is quickly making a significant impact. The company is working toward FDA clearance of its Intelligent Fingerprinting Drug Screening System for the detection of the opiate codeine. FDA clearance would support expansion beyond Forensic Use Only settings into the multi-billion-dollar US drug screening market. The company demonstrated a strong first-half performance in fiscal 2026, with revenue surpassing $2 million, up 36% year-over-year. This performance reflects sustained customer adoption across international markets, with the company adding 49 new customer accounts in the 6-month period.
Opportunity in a Growing Market
The global demand for efficient, rapid drug testing is accelerating. Recent data from Research and Markets shows the global drug screening market is projected to reach US$31.8 billion by 2030. The Drug Screening Products segment alone is projected to reach US$16.7 billion by 2030, with a compound annual growth rate (CAGR) of 14%. This growth trajectory is driven by stronger regulations, a focus on workplace safety, and growing demand for fast, non-invasive testing technologies. Intelligent Bio Solutions is well-positioned to disrupt the traditional testing landscape with its rapid, cost-effective, non-invasive alternative to urine and saliva-based tests.
Drug Use in the Workplace
Workplace drug use is a significant issue. National US data derived from the Substance Abuse and Mental Health Services Administration (SAMHSA) public online data analysis system (PDAS) shows that more than 70% of adults with a substance use disorder (SUD), including alcohol or illicit drug use disorders, are employed. In safety-critical industries such as construction, transportation, and manufacturing, this can lead to a higher risk of accidents, absenteeism, and lower productivity.
Increasing Drug Consumption
The global landscape of drug consumption is evolving rapidly. The United Nations Office on Drugs and Crime (UNODC) World Drug Report 2025 reveals that approximately 316 million people used drugs globally in 2023, a 28% increase over the past decade. Cannabis remains the most used drug, with almost 244 million users, while opioids, despite a smaller user base of 61 million, continue to pose significant health risks, particularly due to the acute threat of synthetic opioids in North America. Stimulant use also continues to be a concern, with 31 million people using amphetamines and 25 million using cocaine, contributing to growing public health challenges across multiple regions.
This rise in drug consumption, driven by social, economic, and health factors, underscores the increasing demand for robust drug screening solutions. As more individuals and organizations face the consequences of drug use, the need for fast, non-invasive, and reliable testing methods becomes critical, not just in workplace settings but across society at large.
Intelligent Bio Solutions is positioned to meet this growing demand through its innovative drug screening technology, offering an effective solution for organizations looking to combat drug misuse with minimal disruption to their operations.
Key Product Advantages
Reduced Risk
The Intelligent Fingerprinting Drug Screening System is designed to detect drug use within a 16–24-hour period. It aims to ensure employees are ‘fit for work’ at the time of testing and reduce the risks associated with potential drug impairment.
Respect for Privacy and Dignity
The non-invasive, fingerprint sweat-based screening method offers a discreet and dignified process, protecting the privacy of individuals and minimizing discomfort compared to traditional methods.
Testing Integrity
The Drug Screening System provides accurate and reliable results, with tamper-evident screening cartridges and a supervised process to prevent foul play or test manipulation.
Expanded Testing Capabilities
The portable Drug Screening System allows screening tests to be conducted at any time and location.
Cost Savings
The Drug Screening System offers a cost-effective alternative to traditional methods, allowing employers to bring drug testing in-house and test on-site quickly and efficiently without requiring specialist staff or facilities.
Increased Efficiency
With results in under ten minutes and batch testing capabilities, the system promotes operational efficiency with minimal workflow disruption.